期刊文献+

益肾平肝方对SHR早期肾损害组织形态学的影响 被引量:7

Histomorphology Effects of YiShen PingGan Decoction Treating the Early Renal Damage of Spontaneous Hypertensive Rat(SHR)
下载PDF
导出
摘要 目的:观察益肾平肝方对自发性高血压大鼠(SHR)早期肾损害组织形态学的影响。方法:将10周龄雄性SHR随机分为模型组(蒸馏水)、中药组(益肾平肝方)、中西药结合组(益肾平肝方+洛汀新)、西药组(洛汀新)、WKY作为正常对照组(蒸馏水),每组8只,用药12周,观察大鼠肾脏的超微结构及四型胶原(CO-Ⅳ)和层黏蛋白(LN)的表达。结果:与模型组相比,益肾平肝方能明显改善SHR的肾脏超微结构,显著降低CO-Ⅳ和LN在肾小球的表达(P<0.01)。结论:益肾平肝方可以减轻高血压病肾脏病理损伤,其作用可能是通过下调促肾小球硬化的细胞因子Co-IV、LN表达,减少ECM在肾小球局部的聚集实现的。 Object: To observe the effects of YiShen PingGan decoction on histomorphology of spontaneously hypertensive rat(SHR) with early renal damage.Methods: The 10-week-old male SHR were randomly divided into model group (distilled water), Chinese medicine group (YiShen PingGan decoction), the combination of western medicine group (YiShen PingGan side and Lotensin), western group(Lotenisn), WKY as normal control group(distilled water), and 8 rats in each group, medicine for 12 weeks.We observed the ultrastructure o the rat liver and the expression of type IV collagen (CO-IV) and laminin (LN).Results: YiShen PingGan decoction can improve the renal ultrastructure in SHR, decrease the expression of type IV collagen(CO-IV) and laminin(LN) in glomeruli(P〈0.01) significantly. Conclusion: YiShen PingGan decoction can reduce the hypertensive renal pathological damage, which may be achieved by down-regulating the expression of cytokines (CO- IV and laminin)promoting glomerular sclerosis, and reducing the ECM accumulation in parts of glomeruli.
出处 《甘肃中医》 2010年第1期28-30,共3页 Gansu Journal of Traditional Chinese Medicine
基金 上海市教育委员会科研项目(编号06CZ012)
关键词 益肾平肝方 自发性高血压大鼠 肾脏 形态学 YiShe n PingGan decoction: SHR renal histomorphology
  • 相关文献

参考文献9

  • 1Seott M. Grundy, Richard Pasterna K,PhiliP Greenland, et al. Assessment of eardiovascular risk by use of MultiPle-Risk-Factor assessment equations. AS taremerit for health care professionals from the american heart assoeiation and the american college of cardiology[J].Circulation,1999,100(13):1481-1492.
  • 2张维忠.高血压治疗研究的回顾与展望[J].中华心血管病杂志,2000,28(3):167-169. 被引量:60
  • 3Ruiz-Ortega M, Ruperez M,Esteban V, et al. Molecular mechanisms of angiotensin II-induced vascular injury [J].Curr Hypertens Rep, 2003,5(1):73-79.
  • 4Ruperez M,Lorenzo O,Blanco-Colio LM, et al. Connective tissue growth factor is a mediator of angiotensin II-induced fibrosis[J].Circulation,2003,108(12): 1499-1505.
  • 5Sugiyama H,Kashihara N, Maeshima Y, et al. Regulation of survival and death of mesangial cells by extracellular matrix[J].Kidney Int,1998,54:1188-1196.
  • 6Rastaldi MP,Ferrario F,Giardino L, et al. Epithelialmesenchymal transition of tubular epithelial cells in human renal biopsies[J].Kidney Int,2002,62 (1): 137-146.
  • 7Andrew Mooney,Kathryn Jackson,Rachel Bacon,et al. Type IV collagen and laminin regulate clomerularmesangial cell susceptibility to apoptosis via β1 integrin-mediated survival signals[J].American journal of pathology, 1999,155(2):599-606.
  • 8Mooney A, Jackson K,Bacon R, et al. Type IV collagen and laminin regulate glomerular mesangial cell susceptibility to apoptosis via beta (1) integrin-mediated survival signals[J].Am J Pathol,1999,155(2): 599-606.
  • 9洪江淮,郑京,王智,吴竞,丘余良,陈雪兰,吴艺,陈淑娇.慢性肾炎血瘀证血尿Col-Ⅳ LN的改变及丹参注射液的作用初探[J].中医药学刊,2006,24(8):1462-1466. 被引量:6

二级参考文献14

共引文献64

同被引文献112

引证文献7

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部